Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Sarcoma, Myeloid × Cladribine × Clear all

Phase

Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 8 Leukemia, Biphenotypic, Acute 5 Sarcoma, Myeloid 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Leukemia, Prolymphocytic, T-Cell 1 Leukemia, Hairy Cell 1

Interventions

venetoclax 1 pegylated granulocyte colony-stimulating factor 1 Mitoxantrone 1 Cytarabine 1 Cladribine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04797767 2025-10-15

Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms

University of Washington

Phase 1/2 Recruiting

Other hematologic neoplasmSarcoma

Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Sarcoma, Myeloid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡